Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes.
- Published In:
- The New England journal of medicine, 391(2), 109-121 (2024)
- Authors:
- Perkovic, Vlado(3), Tuttle, Katherine R(10), Rossing, Peter(6), Mahaffey, Kenneth W, Mann, Johannes F E, Bakris, George, Baeres, Florian M M, Idorn, Thomas, Bosch-Traberg, Heidrun, Lausvig, Nanna Leonora, Pratley, Richard
- Database ID:
- RPEP-09061
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-09061APA
Perkovic, Vlado; Tuttle, Katherine R; Rossing, Peter; Mahaffey, Kenneth W; Mann, Johannes F E; Bakris, George; Baeres, Florian M M; Idorn, Thomas; Bosch-Traberg, Heidrun; Lausvig, Nanna Leonora; Pratley, Richard. (2024). Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes.. The New England journal of medicine, 391(2), 109-121. https://doi.org/10.1056/NEJMoa2403347
MLA
Perkovic, Vlado, et al. "Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes.." The New England journal of medicine, 2024. https://doi.org/10.1056/NEJMoa2403347
RethinkPeptides
RethinkPeptides Research Database. "Effects of Semaglutide on Chronic Kidney Disease in Patients..." RPEP-09061. Retrieved from https://rethinkpeptides.com/research/perkovic-2024-effects-of-semaglutide-on
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.